- Extensive condylomas can progress to high-grade dysplasia, carcinoma in situ and invasive squamous cell carcinoma.
- Delayed presentation with widespread anal, genital, oral and neck condylomas required excision, split-thickness skin grafting, circumcision and diverting colostomy.
- HPV genotyping showed highest titres for types 82 and 6, highlighting potential limitations of Norway's vaccine coverage and disease stigma.
Tidsskr Nor Laegeforen. 2026 Oct 8;146(12). doi: 10.4045/tidsskr.26.0050. Print 2026 Oct 13.
ABSTRACT
BACKGROUND: Condylomas are usually benign lesions associated with human papillomavirus (HPV) infection, but extensive disease can cause substantial morbidity. Immunosuppression can contribute to disease progression.
CASE PRESENTATION: A man presented with a two-year history of extensive condylomas involving the anal and perianal regions, penis, groin, suprapubic region, tongue and neck. Medical evaluation had been delayed due to health anxiety. Surgical treatment comprised excision of all lesions, split-thickness skin grafting, circumcision and a diverting colostomy. Histopathological examination revealed high-grade dysplasia, carcinoma in situ and squamous cell carcinoma in penile and anal lesions. HPV genotyping showed the highest viral titres for HPV types 82 and 6.
INTERPRETATION: Most countries offer HPV vaccines that provide protection against oncogenic HPV types as well as those associated with condylomas. In Norway, the HPV vaccine primarily targets the most common oncogenic HPV types. This case illustrates the potential severity of condylomas and the stigma and health burden associated with the condition. It also highlights possible limitations of current HPV vaccination practice in Norway.
PMID:42885270 | DOI:10.4045/tidsskr.26.0050
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
